Filtros de búsqueda

Lista de obras de Chantal Csajka

ADME pathway approach for pharmacogenetic studies of anti-HIV therapy

artículo científico publicado en 2007

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir

artículo científico publicado en 2010

An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients

artículo científico publicado en 2010

Antimicrobial Agents

Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics

artículo científico publicado en 2011

Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy

artículo científico publicado en 2017

Benchmarking therapeutic drug monitoring software: a review of available computer tools

artículo científico

Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections

artículo científico publicado en 2012

Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.

artículo científico publicado en 2014

Comparison of Population Pharmacokinetics Based on Steady-State Assumption Versus Electronically Monitored Adherence to Lopinavir, Atazanavir, Efavirenz, and Etravirine: A Retrospective Study

artículo científico publicado en 2016

Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study

artículo científico publicado en 2013

Detecting and assessing the impactof anticholinergic medications

artículo científico publicado en 2017

Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy

artículo científico publicado en 2012

Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy

artículo científico publicado en 2011

Dosage optimization of treatments using population pharmacokinetic modeling and simulation

artículo científico publicado en 2012

Effect of Adherence on Pharmacokinetic/Pharmacodynamic Relationships of Oral Targeted Anticancer Drugs

artículo científico publicado en 2017

Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania

artículo científico publicado en 2012

Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherence

artículo científico publicado en 2019

Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainment

scientific article published on 07 July 2019

Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients

artículo científico publicado en 2017

Gender medicine and oncology: report and consensus of an ESMO workshop

scientific article published on 01 December 2019

Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents

artículo científico publicado en 2006

Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort

artículo científico publicado en 2015

High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethate

artículo científico publicado en 2014

Imatinib plasma levels: correlation with clinical benefit in GIST patients

artículo científico publicado en 2010

Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy

artículo científico publicado en 2020

Improved investigations in drug safety by more in-depth individual pharmacokinetics using high-resolution mass spectrometry

In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function

artículo científico publicado en 2009

Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV

scientific article published on 12 April 2020

Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic model

artículo científico publicado en 2013

Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions.

artículo científico publicado en 2014

Mechanistic pharmacokinetic and pharmacodynamic modeling of CHF3381 (2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide monohydrochloride), a novel N-methyl-D-aspartate antagonist and monoamine oxidase-A inhibitor in healthy subjects.

artículo científico publicado en 2005

Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects

artículo científico publicado en 2005

Multiplex liquid chromatography-tandem mass spectrometry assay for simultaneous therapeutic drug monitoring of ribavirin, boceprevir, and telaprevir

artículo científico publicado en 2013

Médicaments et grossesse : modifications pharmacocinétiques et place du suivi thérapeutique pharmacologique

Outbreak in meldonium positive laboratory tests: are we missing something?

artículo científico publicado en 2016

Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals

artículo científico publicado en 2009

Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals

article

Pharmacokinetic and pharmacodynamic analysis of efavirenz dose reduction using an in vitro-in vivo extrapolation model

artículo científico publicado en 2012

Pharmacokinetic-pharmacodynamic modelling: history and perspectives

artículo científico publicado en 2006

Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists.

artículo científico publicado en 1997

Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV

artículo científico publicado en 2020

Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates

artículo científico publicado en 2016

Pharmacometrics-based decision tools facilitate mHealth implementation

artículo científico publicado en 2016

Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients

artículo científico publicado en 2004

Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV

artículo científico publicado en 2019

Population Genetic-Based Pharmacokinetic Modeling of Methadone and its Relationship with the QTc Interval in Opioid-Dependent Patients

artículo científico publicado en 2016

Population Pharmacokinetic Study of Amoxicillin-Treated Burn Patients Hospitalized at a Swiss Tertiary-Care Center

article

Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals

scientific article published on 31 October 2016

Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals

artículo científico publicado en 2012

Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals

artículo científico publicado en 2016

Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance

artículo científico publicado en 2014

Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals

artículo científico publicado en 2014

Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs

artículo científico publicado en 2021

Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates

artículo científico publicado en 2014

Population pharmacokinetic study of memantine: effects of clinical and genetic factors

artículo científico publicado en 2013

Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania

artículo científico publicado en 2014

Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection

artículo científico publicado en 2003

Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection

artículo científico publicado en 2006

Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients.

artículo científico publicado en 2001

Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovir

artículo científico publicado en 2009

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein

artículo científico publicado en 2006

Population pharmacokinetics of indinavir in patients infected with human immunodeficiency virus

artículo científico publicado en 2004

Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients

artículo científico publicado en 2013

Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours

artículo científico publicado en 2013

Prediction of infant drug exposure through breastfeeding: population PK modeling and simulation of fluoxetine exposure.

artículo científico publicado en 2011

Pregnancy Outcome Following Exposure to Topical Retinoids: A Multicenter Prospective Study

scholarly article by Alice Panchaud et al published December 2012 in The Journal of Clinical Pharmacology

Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services

artículo científico publicado en 2017

Principles of therapeutic drug monitoring

artículo científico publicado en 2008

Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry.

artículo científico publicado en 2018

Quantitative analysis of gentamicin exposure in neonates and infants calls into question its current dosing recommendations.

artículo científico publicado en 2018

Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology

scholarly article by Elyes Dahmane et al published April 2014 in Analytical and Bioanalytical Chemistry

Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies

artículo científico publicado en 2008

Relationship of CYP2D6, CYP3A, POR, and ABCB1 genotypes with galantamine plasma concentrations

artículo científico publicado en 2013

Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability

artículo científico publicado en 2008

Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey

article

Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence

artículo científico

SSRI antidepressant use during pregnancy and the assessment of the risk-benefit ratio

artículo científico publicado en 2016

Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis Patients

artículo científico publicado en 2016

Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology

artículo científico

Simultaneous determination of selective serotonin reuptake inhibitors and their main metabolites in human breast milk by liquid chromatography-electrospray mass spectrometry

artículo científico publicado en 2017

Stereoselective determination of citalopram and desmethylcitalopram in human plasma and breast milk by liquid chromatography tandem mass spectrometry

artículo científico publicado en 2016

Systematic review of population pharmacokinetic analyses of imatinib and relationships with treatment outcomes

artículo científico

The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption

artículo científico publicado en 2005

Therapeutic Drug Monitoring of Targeted Anticancer Therapy. Tyrosine Kinase Inhibitors and Selective Estrogen Receptor Modulators: A Clinical Pharmacology Laboratory Perspective

scholarly article published 2012

Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels.

artículo científico publicado en 2012

Therapeutic drug monitoring of targeted anticancer therapy

artículo científico

Therapeutic drug monitoring: clinical practice

artículo científico publicado en 2008

Tobramycin exposure from active calcium sulfate bone graft substitute

artículo científico publicado en 2014

Utility of an Algorithm to Increase the Accuracy of Medication History in an Obstetrical Setting

artículo científico publicado en 2016

Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestry

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda